Copyright Reports & Markets. All rights reserved.

Global Digital Health and Digital Therapeutics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Digital Health and Digital Therapeutics by Type
    • 1.3.1 Overview: Global Digital Health and Digital Therapeutics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Digital Health and Digital Therapeutics Consumption Value Market Share by Type in 2025
    • 1.3.3 Software
    • 1.3.4 Hardware
  • 1.4 Global Digital Health and Digital Therapeutics Market by Application
    • 1.4.1 Overview: Global Digital Health and Digital Therapeutics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cardiovascular Disease
    • 1.4.3 Diabetes
    • 1.4.4 Obesity
    • 1.4.5 Other
  • 1.5 Global Digital Health and Digital Therapeutics Market Size & Forecast
  • 1.6 Global Digital Health and Digital Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Digital Health and Digital Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Digital Health and Digital Therapeutics Market Size by Region, (2021-2032)
    • 1.6.3 North America Digital Health and Digital Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Digital Health and Digital Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Digital Health and Digital Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.6 South America Digital Health and Digital Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Digital Health and Digital Therapeutics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Canary Health
    • 2.1.1 Canary Health Details
    • 2.1.2 Canary Health Major Business
    • 2.1.3 Canary Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.1.4 Canary Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Canary Health Recent Developments and Future Plans
  • 2.2 Livongo
    • 2.2.1 Livongo Details
    • 2.2.2 Livongo Major Business
    • 2.2.3 Livongo Digital Health and Digital Therapeutics Product and Solutions
    • 2.2.4 Livongo Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Livongo Recent Developments and Future Plans
  • 2.3 My mHealth
    • 2.3.1 My mHealth Details
    • 2.3.2 My mHealth Major Business
    • 2.3.3 My mHealth Digital Health and Digital Therapeutics Product and Solutions
    • 2.3.4 My mHealth Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 My mHealth Recent Developments and Future Plans
  • 2.4 Omada
    • 2.4.1 Omada Details
    • 2.4.2 Omada Major Business
    • 2.4.3 Omada Digital Health and Digital Therapeutics Product and Solutions
    • 2.4.4 Omada Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Omada Recent Developments and Future Plans
  • 2.5 Otsuka (Proteus)
    • 2.5.1 Otsuka (Proteus) Details
    • 2.5.2 Otsuka (Proteus) Major Business
    • 2.5.3 Otsuka (Proteus) Digital Health and Digital Therapeutics Product and Solutions
    • 2.5.4 Otsuka (Proteus) Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Otsuka (Proteus) Recent Developments and Future Plans
  • 2.6 Virgin Pulse
    • 2.6.1 Virgin Pulse Details
    • 2.6.2 Virgin Pulse Major Business
    • 2.6.3 Virgin Pulse Digital Health and Digital Therapeutics Product and Solutions
    • 2.6.4 Virgin Pulse Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Virgin Pulse Recent Developments and Future Plans
  • 2.7 DarioHealth Corp
    • 2.7.1 DarioHealth Corp Details
    • 2.7.2 DarioHealth Corp Major Business
    • 2.7.3 DarioHealth Corp Digital Health and Digital Therapeutics Product and Solutions
    • 2.7.4 DarioHealth Corp Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 DarioHealth Corp Recent Developments and Future Plans
  • 2.8 2Morrow
    • 2.8.1 2Morrow Details
    • 2.8.2 2Morrow Major Business
    • 2.8.3 2Morrow Digital Health and Digital Therapeutics Product and Solutions
    • 2.8.4 2Morrow Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 2Morrow Recent Developments and Future Plans
  • 2.9 Click Therapeutics
    • 2.9.1 Click Therapeutics Details
    • 2.9.2 Click Therapeutics Major Business
    • 2.9.3 Click Therapeutics Digital Health and Digital Therapeutics Product and Solutions
    • 2.9.4 Click Therapeutics Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Click Therapeutics Recent Developments and Future Plans
  • 2.10 CureApp
    • 2.10.1 CureApp Details
    • 2.10.2 CureApp Major Business
    • 2.10.3 CureApp Digital Health and Digital Therapeutics Product and Solutions
    • 2.10.4 CureApp Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 CureApp Recent Developments and Future Plans
  • 2.11 AppliedVR
    • 2.11.1 AppliedVR Details
    • 2.11.2 AppliedVR Major Business
    • 2.11.3 AppliedVR Digital Health and Digital Therapeutics Product and Solutions
    • 2.11.4 AppliedVR Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AppliedVR Recent Developments and Future Plans
  • 2.12 Virta Health
    • 2.12.1 Virta Health Details
    • 2.12.2 Virta Health Major Business
    • 2.12.3 Virta Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.12.4 Virta Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Virta Health Recent Developments and Future Plans
  • 2.13 Biofourmis
    • 2.13.1 Biofourmis Details
    • 2.13.2 Biofourmis Major Business
    • 2.13.3 Biofourmis Digital Health and Digital Therapeutics Product and Solutions
    • 2.13.4 Biofourmis Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Biofourmis Recent Developments and Future Plans
  • 2.14 Akili Interactive
    • 2.14.1 Akili Interactive Details
    • 2.14.2 Akili Interactive Major Business
    • 2.14.3 Akili Interactive Digital Health and Digital Therapeutics Product and Solutions
    • 2.14.4 Akili Interactive Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Akili Interactive Recent Developments and Future Plans
  • 2.15 Pear Therapeutics
    • 2.15.1 Pear Therapeutics Details
    • 2.15.2 Pear Therapeutics Major Business
    • 2.15.3 Pear Therapeutics Digital Health and Digital Therapeutics Product and Solutions
    • 2.15.4 Pear Therapeutics Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Pear Therapeutics Recent Developments and Future Plans
  • 2.16 Provant Health
    • 2.16.1 Provant Health Details
    • 2.16.2 Provant Health Major Business
    • 2.16.3 Provant Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.16.4 Provant Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Provant Health Recent Developments and Future Plans
  • 2.17 Lark Health
    • 2.17.1 Lark Health Details
    • 2.17.2 Lark Health Major Business
    • 2.17.3 Lark Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.17.4 Lark Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Lark Health Recent Developments and Future Plans
  • 2.18 Propeller Health
    • 2.18.1 Propeller Health Details
    • 2.18.2 Propeller Health Major Business
    • 2.18.3 Propeller Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.18.4 Propeller Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Propeller Health Recent Developments and Future Plans
  • 2.19 Cognoa
    • 2.19.1 Cognoa Details
    • 2.19.2 Cognoa Major Business
    • 2.19.3 Cognoa Digital Health and Digital Therapeutics Product and Solutions
    • 2.19.4 Cognoa Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Cognoa Recent Developments and Future Plans
  • 2.20 Kaia Health
    • 2.20.1 Kaia Health Details
    • 2.20.2 Kaia Health Major Business
    • 2.20.3 Kaia Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.20.4 Kaia Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Kaia Health Recent Developments and Future Plans
  • 2.21 Happify Health
    • 2.21.1 Happify Health Details
    • 2.21.2 Happify Health Major Business
    • 2.21.3 Happify Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.21.4 Happify Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Happify Health Recent Developments and Future Plans
  • 2.22 Welldoc
    • 2.22.1 Welldoc Details
    • 2.22.2 Welldoc Major Business
    • 2.22.3 Welldoc Digital Health and Digital Therapeutics Product and Solutions
    • 2.22.4 Welldoc Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 Welldoc Recent Developments and Future Plans
  • 2.23 Mango Health
    • 2.23.1 Mango Health Details
    • 2.23.2 Mango Health Major Business
    • 2.23.3 Mango Health Digital Health and Digital Therapeutics Product and Solutions
    • 2.23.4 Mango Health Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.23.5 Mango Health Recent Developments and Future Plans
  • 2.24 Wellthy Therapeutics
    • 2.24.1 Wellthy Therapeutics Details
    • 2.24.2 Wellthy Therapeutics Major Business
    • 2.24.3 Wellthy Therapeutics Digital Health and Digital Therapeutics Product and Solutions
    • 2.24.4 Wellthy Therapeutics Digital Health and Digital Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.24.5 Wellthy Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Digital Health and Digital Therapeutics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Digital Health and Digital Therapeutics by Company Revenue
    • 3.2.2 Top 3 Digital Health and Digital Therapeutics Players Market Share in 2025
    • 3.2.3 Top 6 Digital Health and Digital Therapeutics Players Market Share in 2025
  • 3.3 Digital Health and Digital Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Digital Health and Digital Therapeutics Market: Region Footprint
    • 3.3.2 Digital Health and Digital Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Digital Health and Digital Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Digital Health and Digital Therapeutics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Digital Health and Digital Therapeutics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Digital Health and Digital Therapeutics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Digital Health and Digital Therapeutics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Digital Health and Digital Therapeutics Consumption Value by Type (2021-2032)
  • 6.2 North America Digital Health and Digital Therapeutics Market Size by Application (2021-2032)
  • 6.3 North America Digital Health and Digital Therapeutics Market Size by Country
    • 6.3.1 North America Digital Health and Digital Therapeutics Consumption Value by Country (2021-2032)
    • 6.3.2 United States Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Digital Health and Digital Therapeutics Consumption Value by Type (2021-2032)
  • 7.2 Europe Digital Health and Digital Therapeutics Consumption Value by Application (2021-2032)
  • 7.3 Europe Digital Health and Digital Therapeutics Market Size by Country
    • 7.3.1 Europe Digital Health and Digital Therapeutics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.3 France Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Digital Health and Digital Therapeutics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Digital Health and Digital Therapeutics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Digital Health and Digital Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Digital Health and Digital Therapeutics Consumption Value by Region (2021-2032)
    • 8.3.2 China Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.5 India Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Digital Health and Digital Therapeutics Consumption Value by Type (2021-2032)
  • 9.2 South America Digital Health and Digital Therapeutics Consumption Value by Application (2021-2032)
  • 9.3 South America Digital Health and Digital Therapeutics Market Size by Country
    • 9.3.1 South America Digital Health and Digital Therapeutics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Digital Health and Digital Therapeutics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Digital Health and Digital Therapeutics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Digital Health and Digital Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Digital Health and Digital Therapeutics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Digital Health and Digital Therapeutics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Digital Health and Digital Therapeutics Market Drivers
  • 11.2 Digital Health and Digital Therapeutics Market Restraints
  • 11.3 Digital Health and Digital Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Digital Health and Digital Therapeutics Industry Chain
  • 12.2 Digital Health and Digital Therapeutics Upstream Analysis
  • 12.3 Digital Health and Digital Therapeutics Midstream Analysis
  • 12.4 Digital Health and Digital Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Digital Health and Digital Therapeutics market size was valued at US$ 4186 million in 2025 and is forecast to a readjusted size of US$ 6907 million by 2032 with a CAGR of 7.5% during review period.
    Digital Health and Digital Therapeutics refers to medical technologies that prevent, manage or treat specific diseases through clinically validated software and applications, using digital technology to improve the overall areas of health management, disease prevention, diagnosis, treatment and patient care, covering telemedicine, health monitoring devices, health applications, data analysis, etc.
    In recent years, the fields of digital health and digital therapeutics (DTx) are developing rapidly and have become an important part of innovation in the global medical industry. Through technology empowerment, these two fields have improved the efficiency, accessibility and personalization of medical services, and have also promoted profound changes in the way health is managed. From telemedicine to smart health devices to software-based treatment plans, digital health and digital therapy provide patients around the world with more convenient, accurate and personalized medical options.
    Digital health is a comprehensive field that covers a wide range of technological applications, such as telemedicine, mobile health applications, health monitoring devices, and health big data analysis. With the increasing severity of global health problems, especially the advent of an aging society, the demand for the digital health market has risen sharply.
    The rapid growth of digital health is driven by many factors. First, with the aging of the global population, the incidence of chronic diseases and geriatric diseases has increased, and there is an urgent need for more efficient and convenient health management methods. Second, the advancement of smart devices and mobile Internet technology has made personal health monitoring and management more feasible. For example, smart watches, health monitoring sensors, wearable devices, etc. have become part of daily life, which can collect health data and provide feedback in real time to help users understand their health status. The popularity of telemedicine and video consultations also allows patients to obtain professional medical services anytime and anywhere, reducing the time and geographical restrictions of traditional medical treatment models.
    However, despite the rapid development of the digital health market, it also faces some challenges. For example, data privacy and security issues remain core issues in the field of digital health. How to ensure the security of patient data and how to achieve data interoperability and sharing in different medical systems are currently urgent issues to be solved.
    This report is a detailed and comprehensive analysis for global Digital Health and Digital Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Digital Health and Digital Therapeutics market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Digital Health and Digital Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Digital Health and Digital Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Digital Health and Digital Therapeutics market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Digital Health and Digital Therapeutics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Digital Health and Digital Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Canary Health, Livongo, My mHealth, Omada, Otsuka (Proteus), Virgin Pulse, DarioHealth Corp, 2Morrow, Click Therapeutics, CureApp, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Digital Health and Digital Therapeutics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Software
    Hardware
    Market segment by Application
    Cardiovascular Disease
    Diabetes
    Obesity
    Other
    Market segment by players, this report covers
    Canary Health
    Livongo
    My mHealth
    Omada
    Otsuka (Proteus)
    Virgin Pulse
    DarioHealth Corp
    2Morrow
    Click Therapeutics
    CureApp
    AppliedVR
    Virta Health
    Biofourmis
    Akili Interactive
    Pear Therapeutics
    Provant Health
    Lark Health
    Propeller Health
    Cognoa
    Kaia Health
    Happify Health
    Welldoc
    Mango Health
    Wellthy Therapeutics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Digital Health and Digital Therapeutics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Digital Health and Digital Therapeutics, with revenue, gross margin, and global market share of Digital Health and Digital Therapeutics from 2021 to 2026.
    Chapter 3, the Digital Health and Digital Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Digital Health and Digital Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Health and Digital Therapeutics.
    Chapter 13, to describe Digital Health and Digital Therapeutics research findings and conclusion.

    Buy now